Myriad Genetics Inc - Company Profile
Powered by 
All the data and insights you need on Myriad Genetics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Myriad Genetics Inc Strategy Report
- Understand Myriad Genetics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, engaged in the discovery and commercialization of molecular diagnostic tests, and personalized medicine, and provides pharmaceutical and clinical services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, genetic expressions, and corresponding proteins to assess a person’s risk for developing diseases later in life; products related to diagnosis of disease; and determine a patient’s likelihood of responding to a particular drug. Myriad markets its products through sales force in Europe and Canada and distributor agreements in countries in Canada, Middle East, Asia, and Australia. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, Italy, Germany, Japan, Australia and the Netherlands. Myriad is headquartered in Salt Lake City, Utah, the US.
Headquarters
United States of America
Address
322 North 2200 West, Salt Lake City, Utah, 84116
Website
www.myriad.com
Telephone
1 801 5843600
No of Employees
2,700
Industry
Medical Equipment
Ticker Symbol & Exchange
MYGN (NASD)
Revenue (2022)
$753.2M
11%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-135.1%
(2022 vs 2021)
Market Cap*
$1.8B
Net Profit Margin (2022)
XYZ
-111.8%
(2022 vs 2021)
* As of and is in US$
Myriad Genetics Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| BRAC Analysis | Tests: | Myriad genetics |
| Colaris | Prenatal Care | BRACAnalysis |
| Colaris Ap | Fetal Sex | BRACAnalysis CDx |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In May, the company signed an agreement to sell the rights to a second-generation gene expression test for breast cancer, EndoPredict to Eurobio Scientific. |
| 2024 | Patent Grant | In March, the company was granted patent for SneakPeek Snap Device. |
| 2024 | Acquisitions/Mergers/Takeovers | In February, the company completed the acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics. |
Competitor Comparison
| Key Parameters | Myriad Genetics Inc | Quest Diagnostics Inc | Hologic Inc | Exact Sciences Corp | Natera Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Salt Lake City | Secaucus | Marlborough | Madison | Austin |
| State/Province | Utah | New Jersey | Massachusetts | Wisconsin | Texas |
| No. of Employees | 2,700 | 40,000 | 6,990 | 6,500 | 3,282 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Paul J. Diaz | Chief Executive Officer; President; Director | Executive Board | 2020 | 62 |
| S. Louise Phanstiel | Chair | Executive Board | 2020 | 65 |
| Scott J. Leffler | Chief Financial Officer | Senior Management | 2024 | 49 |
| Sam S. Raha | Chief Operating Officer | Senior Management | 2023 | 52 |
| Kevin R. Haas | Chief Technology Officer | Senior Management | 2021 | 39 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer